메뉴 건너뛰기




Volumn 20, Issue 1, 2011, Pages 160-171

Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancer

(20)  Matsubara, Junichi a,b   Honda, Kazufumi a   Ono, Masaya a   Tanaka, Yoshinori c   Kobayashi, Michimoto c   Jung, Giman c   Yanagisawa, Koji d   Sakuma, Tomohiro d   Nakamori, Shoji e   Sata, Naohiro f   Nagai, Hideo f   Ioka, Tatsuya g   Okusaka, Takuji h   Kosuge, Tomoo h   Tsuchida, Akihiko i   Shimahara, Masashi j   Yasunami, Yohichi k   Chiba, Tsutomu b   Hirohashi, Setsuo a   Yamada, Tesshi a  


Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CHEMOKINE; CXC CHEMOKINE LIGAND 7; PEPTIDE; TUMOR MARKER; UNCLASSIFIED DRUG;

EID: 78651424414     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0397     Document Type: Article
Times cited : (38)

References (43)
  • 3
    • 78651456659 scopus 로고    scopus 로고
    • Ministry of Health, Labour and Welfare. Japanese Government: vital statistics of Japan
    • Ministry of Health, Labour and Welfare. Japanese Government: vital statistics of Japan2009. Available from: http://ganjoho.ncc.go.jp/professional/ statistics/odjrh3000000hwsa-att/cancer-mortality(1958- 2008).xls.
    • (2009)
  • 4
    • 33947593200 scopus 로고    scopus 로고
    • American Cancer Society, Atlanta, GA: American Cancer Society
    • American Cancer Society. Cancer Facts and Figures2007. Atlanta, GA: American Cancer Society; 2007. p. 16-7.
    • (2007) Cancer Facts and Figures 2007 , pp. 16-17
  • 5
    • 0028888708 scopus 로고
    • Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
    • Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995;221:59-66.
    • (1995) Ann Surg , vol.221 , pp. 59-66
    • Nitecki, S.S.1    Sarr, M.G.2    Colby, T.V.3    Van Heerden, J.A.4
  • 7
    • 0032760453 scopus 로고    scopus 로고
    • AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma
    • American Gastroenterological Association
    • DiMagno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 1999;117:1464-84.
    • (1999) Gastroenterology , vol.117 , pp. 1464-1484
    • Dimagno, E.P.1    Reber, H.A.2    Tempero, M.A.3
  • 8
    • 45749089796 scopus 로고    scopus 로고
    • Metastatic pancreatic cancer 2008: Is the glass less empty?
    • Nieto J, Grossbard ML, Kozuch P. Metastatic pancreatic cancer 2008: is the glass less empty?Oncologist 2008;13:562-76.
    • (2008) Oncologist , vol.13 , pp. 562-576
    • Nieto, J.1    Grossbard, M.L.2    Kozuch, P.3
  • 9
    • 8244254377 scopus 로고    scopus 로고
    • Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
    • Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15: 2403-13.
    • (1997) J Clin Oncol , vol.15 , pp. 2403-2413
    • Burris III, H.A.1    Moore, M.J.2    Andersen, J.3    Green, M.R.4    Rothenberg, M.L.5    Modiano, M.R.6
  • 10
    • 68949114505 scopus 로고    scopus 로고
    • Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: A trial of the Eastern Cooperative Oncology Group
    • Poplin E, Feng Y, Berlin J, Rothenberg ML, Hochster H, Mitchell E, et al. Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2009;27:3778-85.
    • (2009) J Clin Oncol , vol.27 , pp. 3778-3785
    • Poplin, E.1    Feng, Y.2    Berlin, J.3    Rothenberg, M.L.4    Hochster, H.5    Mitchell, E.6
  • 11
    • 78651419575 scopus 로고    scopus 로고
    • NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma V.1. National Comprehensive Cancer Network; 2009
    • NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma V.1. National Comprehensive Cancer Network; 2009
  • 12
    • 22844448456 scopus 로고    scopus 로고
    • Molecular markers of early pancreatic cancer
    • Goggins M. Molecular markers of early pancreatic cancer. J Clin Oncol 2005;23:4524-31.
    • (2005) J Clin Oncol , vol.23 , pp. 4524-4531
    • Goggins, M.1
  • 13
    • 0033845951 scopus 로고    scopus 로고
    • Can we screen high-risk individuals to detect early pancreatic carcinoma?
    • Goggins M, Canto M, Hruban R. Can we screen high-risk individuals to detect early pancreatic carcinoma?J Surg Oncol 2000; 74:243-8.
    • (2000) J Surg Oncol , vol.74 , pp. 243-248
    • Goggins, M.1    Canto, M.2    Hruban, R.3
  • 14
    • 0037434981 scopus 로고    scopus 로고
    • Disease proteomics
    • Hanash S. Disease proteomics. Nature 2003;422:226-32.
    • (2003) Nature , vol.422 , pp. 226-232
    • Hanash, S.1
  • 17
    • 33746285299 scopus 로고    scopus 로고
    • Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry
    • Ono M, Shitashige M, Honda K, Isobe T, Kuwabara H, Matsuzuki H, et al. Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry. Mol Cell Proteomics 2006;5:1338-47.
    • (2006) Mol Cell Proteomics , vol.5 , pp. 1338-1347
    • Ono, M.1    Shitashige, M.2    Honda, K.3    Isobe, T.4    Kuwabara, H.5    Matsuzuki, H.6
  • 18
    • 65549144136 scopus 로고    scopus 로고
    • Identification of a predictive biomarker for hematologic toxicities of gemcitabine
    • Matsubara J, Ono M, Negishi A, Ueno H, Okusaka T, Furuse J, et al. Identification of a predictive biomarker for hematologic toxicities of gemcitabine. J Clin Oncol 2009;27:2261-8.
    • (2009) J Clin Oncol , vol.27 , pp. 2261-2268
    • Matsubara, J.1    Ono, M.2    Negishi, A.3    Ueno, H.4    Okusaka, T.5    Furuse, J.6
  • 19
    • 62849128405 scopus 로고    scopus 로고
    • Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry
    • Negishi A, Ono M, Handa Y, Kato H, Yamashita K, Honda K, et al. Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry. Cancer Sci 2009;100: 514-9.
    • (2009) Cancer Sci , vol.100 , pp. 514-519
    • Negishi, A.1    Ono, M.2    Handa, Y.3    Kato, H.4    Yamashita, K.5    Honda, K.6
  • 20
    • 70350400752 scopus 로고    scopus 로고
    • Prolyl 4-hydroxylation of alpha-fibrinogen: A novel protein modification revealed by plasma proteomics
    • Ono M, Matsubara J, Honda K, Sakuma T, Hashiguchi T, Nose H, et al. Prolyl 4-hydroxylation of alpha-fibrinogen: a novel protein modification revealed by plasma proteomics. J Biol Chem 2009;284:29041-9.
    • (2009) J Biol Chem , vol.284 , pp. 29041-29049
    • Ono, M.1    Matsubara, J.2    Honda, K.3    Sakuma, T.4    Hashiguchi, T.5    Nose, H.6
  • 21
    • 0001644020 scopus 로고    scopus 로고
    • The human plasma proteome: History, character, and diagnostic prospects
    • Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1:845-67.
    • (2002) Mol Cell Proteomics , vol.1 , pp. 845-867
    • Anderson, N.L.1    Anderson, N.G.2
  • 22
    • 33748575600 scopus 로고    scopus 로고
    • A novel approach and protocol for discovering extremely low-abundance proteins in serum
    • Tanaka Y, Akiyama H, Kuroda T, Jung G, Tanahashi K, Sugaya H, et al. A novel approach and protocol for discovering extremely low-abundance proteins in serum. Proteomics 2006;6:4845-55.
    • (2006) Proteomics , vol.6 , pp. 4845-4855
    • Tanaka, Y.1    Akiyama, H.2    Kuroda, T.3    Jung, G.4    Tanahashi, K.5    Sugaya, H.6
  • 23
    • 0036649486 scopus 로고    scopus 로고
    • The role of proteomics in toxicology: Identification of biomarkers of toxicity by protein expression analysis
    • Kennedy S. The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis. Biomarkers 2002;7:269-90.
    • (2002) Biomarkers , vol.7 , pp. 269-290
    • Kennedy, S.1
  • 25
    • 78651446737 scopus 로고    scopus 로고
    • Available from
    • Available from: http://www.fhcrc.org/science/international-biomarker/.
  • 26
    • 11144279340 scopus 로고    scopus 로고
    • Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer
    • Honda K, Yamada T, Hayashida Y, Idogawa M, Sato S, Hasegawa F, et al. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology 2005;128:51-62.
    • (2005) Gastroenterology , vol.128 , pp. 51-62
    • Honda, K.1    Yamada, T.2    Hayashida, Y.3    Idogawa, M.4    Sato, S.5    Hasegawa, F.6
  • 27
    • 20444503830 scopus 로고    scopus 로고
    • Poly (ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/beta-catenin complex
    • Idogawa M, Yamada T, Honda K, Sato S, Imai K, Hirohashi S. Poly (ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/beta-catenin complex. Gastroenterology 2005;128:1919-36.
    • (2005) Gastroenterology , vol.128 , pp. 1919-1936
    • Idogawa, M.1    Yamada, T.2    Honda, K.3    Sato, S.4    Imai, K.5    Hirohashi, S.6
  • 28
    • 77950663765 scopus 로고    scopus 로고
    • Survival prediction for pancreatic cancer patients receiving gemcitabine treatment
    • Matsubara J, Ono M, Honda K, Negishi A, Ueno H, Okusaka T, et al. Survival prediction for pancreatic cancer patients receiving gemcitabine treatment. Mol Cell Proteomics 2010;9:695-704.
    • (2010) Mol Cell Proteomics , vol.9 , pp. 695-704
    • Matsubara, J.1    Ono, M.2    Honda, K.3    Negishi, A.4    Ueno, H.5    Okusaka, T.6
  • 29
    • 66649092902 scopus 로고    scopus 로고
    • Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer
    • Fiedler GM, Leichtle AB, Kase J, Baumann S, Ceglarek U, Felix K, et al. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Clin Cancer Res 2009;15:3812-9.
    • (2009) Clin Cancer Res , vol.15 , pp. 3812-3819
    • Fiedler, G.M.1    Leichtle, A.B.2    Kase, J.3    Baumann, S.4    Ceglarek, U.5    Felix, K.6
  • 30
    • 10744223905 scopus 로고    scopus 로고
    • Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry
    • Koopmann J, Zhang Z, White N, Rosenzweig J, Fedarko N, Jagannath S, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 2004;10:860-8.
    • (2004) Clin Cancer Res , vol.10 , pp. 860-868
    • Koopmann, J.1    Zhang, Z.2    White, N.3    Rosenzweig, J.4    Fedarko, N.5    Jagannath, S.6
  • 31
    • 11144353917 scopus 로고    scopus 로고
    • Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers
    • Koopmann J, Buckhaults P, Brown DA, Zahurak ML, Sato N, Fukushima N, et al. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res 2004;10:2386-92.
    • (2004) Clin Cancer Res , vol.10 , pp. 2386-2392
    • Koopmann, J.1    Buckhaults, P.2    Brown, D.A.3    Zahurak, M.L.4    Sato, N.5    Fukushima, N.6
  • 32
    • 0032784841 scopus 로고    scopus 로고
    • Usefulness of novel tumour markers
    • Rhodes JM. Usefulness of novel tumour markers. Ann Oncol 1999;10Suppl 4:118-21.
    • (1999) Ann Oncol , vol.10 , Issue.SUPPL. 4 , pp. 118-121
    • Rhodes, J.M.1
  • 34
    • 0037424253 scopus 로고    scopus 로고
    • Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2
    • Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR, et al. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem 2003;278:8508-15.
    • (2003) J Biol Chem , vol.278 , pp. 8508-8515
    • Heidemann, J.1    Ogawa, H.2    Dwinell, M.B.3    Rafiee, P.4    Maaser, C.5    Gockel, H.R.6
  • 35
    • 33846613303 scopus 로고    scopus 로고
    • Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease
    • Aivado M, Spentzos D, Germing U, Alterovitz G, Meng XY, Grall F, et al. Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease. Proc Natl Acad Sci USA 2007;104:1307-12.
    • (2007) Proc Natl Acad Sci USA , vol.104 , pp. 1307-1312
    • Aivado, M.1    Spentzos, D.2    Germing, U.3    Alterovitz, G.4    Meng, X.Y.5    Grall, F.6
  • 36
    • 67649971550 scopus 로고    scopus 로고
    • Connective tissue-activating peptide III: A novel blood biomarker for early lung cancer detection
    • Yee J, Sadar MD, Sin DD, Kuzyk M,Xing L, Kondra J, et al. Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection. J Clin Oncol 2009;27:2787-92.
    • (2009) J Clin Oncol , vol.27 , pp. 2787-2792
    • Yee, J.1    Sadar, M.D.2    Sin, D.D.3    Kuzyk Mxing, L.4    Kondra, J.5
  • 37
    • 0034332187 scopus 로고    scopus 로고
    • Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein
    • Ehlert JE, Ludwig A, Grimm TA, Lindner B, Flad HD, Brandt E. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein. Blood 2000;96:2965-72.
    • (2000) Blood , vol.96 , pp. 2965-2972
    • Ehlert, J.E.1    Ludwig, A.2    Grimm, T.A.3    Lindner, B.4    Flad, H.D.5    Brandt, E.6
  • 38
    • 33646401341 scopus 로고    scopus 로고
    • Monocyte-derived CXCL7 peptides in the marrow microenvironment
    • Pillai MM, Iwata M, Awaya N, Graf L, Torok-Storb B. Monocyte-derived CXCL7 peptides in the marrow microenvironment. Blood 2006;107:3520-6.
    • (2006) Blood , vol.107 , pp. 3520-3526
    • Pillai, M.M.1    Iwata, M.2    Awaya, N.3    Graf, L.4    Torok-Storb, B.5
  • 40
    • 0034667542 scopus 로고    scopus 로고
    • Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact
    • Van Den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 2000;96:2673-81.
    • (2000) Blood , vol.96 , pp. 2673-2681
    • Van Den Steen, P.E.1    Proost, P.2    Wuyts, A.3    Van Damme, J.4    Opdenakker, G.5
  • 41
    • 51349092847 scopus 로고    scopus 로고
    • Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients
    • Tian M, Cui YZ, Song GH, Zong MJ, Zhou XY, Chen Y, et al. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer 2008;8:241.
    • (2008) BMC Cancer , vol.8 , pp. 241
    • Tian, M.1    Cui, Y.Z.2    Song, G.H.3    Zong, M.J.4    Zhou, X.Y.5    Chen, Y.6
  • 42
    • 0030009878 scopus 로고    scopus 로고
    • Molecular oncology in pancreatic cancer
    • Gansauge S, Gansauge F, Beger HG. Molecular oncology in pancreatic cancer. J Mol Med 1996;74:313-20.
    • (1996) J Mol Med , vol.74 , pp. 313-320
    • Gansauge, S.1    Gansauge, F.2    Beger, H.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.